User:Minkyuleokim/Rexahn Pharmaceuticals

This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft.  Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL Easy tools: Citation bot (help) | Advanced: Fix bare URLs This page was last edited by [[User:|]] ([[User talk:|talk]] | contribs) 0 seconds ago. (Update timer) Finished writing a draft article? Are you ready to request an experienced editor review it for possible inclusion in Wikipedia? Save your work by pressing the "Publish page" button below, and a button will appear here allowing you to submit your draft for review.

Rexahn Pharmaceuticals, Inc. (AMEX: RNN)| ^[1]develops clinical stage drugs that address unmet medical needs in the treatment of cancer, central nervous system (CNS) disorders, and sexual dysfunction. Rexahn Pharmaceuticals is located in Rockville, Maryland (MD), USA, and runs a research facility in Germantown, MD, USA. Rexahn has recently completed Phase II clinical trials for major depressive disorders (MDD) and erectile dysfunction (ED). It is also testing Archexin™ for the treatment of metastatic pancreatic cancer.